
Market Clearance
We help you turn authorization into readiness. Clearance opens the market, but reimbursement, pricing, and a prepared commercial team determine whether your device gains traction.
Please fill out the form below and someone from our team will contact you shortly.
Phase overview
Market Clearance begins when the FDA grants clearance or approval and you are authorized to market your device. The regulatory decision opens the door to commercial activity but doesn’t guarantee commercial success. Reimbursement, pricing and contracting, sales enablement, and channel readiness all need to be in place before clearance can turn into revenue. This is the phase where the work done during review is finalized and activated.
What happens in this phase
Each phase draws on a different combination of our disciplines and sub-disciplines. These are the ones that turn regulatory authorization into commercial readiness.
Reimbursement
Payer engagement led to secure coverage and a clear economic pathway before the first order.
Pricing
Pricing finalized and contracting approach defined for target accounts.
Health System Access
Value analysis committee, IDN, and GPO strategies activated for priority accounts.
Launch Planning
Launch readiness confirmed, with your internal team and channel partners prepared for coordinated market entry.
Marketing Programs
Sales enablement tools, objection handling, and evidence summaries delivered to the field team.
Brand Strategy
Positioning and messaging aligned to the cleared indication and claims.

What you walk away with
You leave Market Clearance with payer engagement underway, pricing and contracting finalized, and health system strategies active for priority accounts. Your internal team and channel partners are prepared for a coordinated market entry, your field team is equipped with sales enablement tools, and your positioning reflects exactly what the clearance permits.
Why this phase matters
Clearance is often mistaken for the finish line. It authorizes commercial activity, but it doesn’t mean clinicians will change practice, payers will cover the device, or accounts will buy it. Companies that treat clearance as a starting point, with reimbursement resolved and the field team prepared, move faster from authorization to adoption.

Commercial Launch
With reimbursement in motion and the team prepared, the program moves into launch, where the device enters the market and traction begins.
Please feel out the form below and someone from our team will contact you shortly.